Tang-Christensen M, Kristensen P, Stidsen C E, Brand C L, Larsen P J
Institute of Medical Anatomy Section B, The Panum Institute, University of Copenhagen, Copenhagen, Denmark.
J Endocrinol. 1998 Nov;159(2):307-12. doi: 10.1677/joe.0.1590307.
A number of neuropeptide Y (NPY) receptor subtypes, including the recently cloned Y5 receptor, have been implicated in the stimulation of food intake. In the present study, Y5 receptor antisense oligodeoxynucleotides (ODNs) were used to assess the potential involvement of the Y5 receptor in the regulation of spontaneous as well as NPY-induced food intake. Repeated central administration of Y5 antisense ODN significantly decreased spontaneous food intake and subsequently resulted in a significant weight loss. Furthermore, Y5 antisense ODN pre-treatment significantly inhibited the robust feeding response elicited by central administration of NPY (5.3+/-0. 8 vs 1.08+/-0.28 g, vehicle+/-s.e.m. vs Y5 ODN+/-s.e.m.). The present results provide evidence that central Y5 receptors are involved in both spontaneous as well as NPY-induced food intake, which may prove to be a new therapeutic route in the treatment of obesity and other disorders of appetite.
包括最近克隆出的Y5受体在内的多种神经肽Y(NPY)受体亚型都与食物摄入的刺激有关。在本研究中,Y5受体反义寡脱氧核苷酸(ODN)被用于评估Y5受体在调节自发性以及NPY诱导的食物摄入中可能发挥的作用。重复进行Y5反义ODN的中枢给药显著降低了自发性食物摄入量,并随后导致了显著的体重减轻。此外,Y5反义ODN预处理显著抑制了中枢注射NPY引发的强烈进食反应(5.3±0.8克与1.08±0.28克,载体±标准误与Y5 ODN±标准误)。目前的结果提供了证据,表明中枢Y5受体参与了自发性以及NPY诱导的食物摄入,这可能被证明是治疗肥胖症和其他食欲紊乱的一条新的治疗途径。